|
Article References
Barrett-Connor E, von Mühlen D, Laughlin GA and
Kripke A. “Endogenous levels of
dehydroepiandrosterone sulfate, but not other sex
hormones, are associated with depressed mood in
older women: The Rancho Bernardo Study.” J Am
Geriatr Soc (1999) 47:685–91.
Baulieu EE, Thomas G, Legrain S, et al.
“Dehydroepiandrosterone (DHEA), DHEA sulfate, and
aging: contribution of the DHEA Age Study to a
sociobiomedical issue.” Proc Natl Acad Sci U S A
(2000) 97:4279–84.
Berton, E., Hoover, D., Fein, H., Galloway, R.,
Smallridge, R., “Adaptation to Chronic Stress in
Military trainees: Adrenal Androgens, Testosterone,
Glucocorticoids, IGF-1 and Immune Function,
Dehydroepiandrosterone (DHEA) and Aging.” New
York Academy of Sciences Meeting (1995) June
17-19
Birkenhager-Gillesse EG, Derksen J, Lagaay AM.
“Dehydroepiandrosterone sulphate (DHEAS) in the
oldest old, aged 85 and over.” Ann N Y Acad Sci
(1994) 719:543–52.
Bowers LD. “Oral dehydroepiandrosterone
supplementation can increase the testosterone/epitestosterone
ratio.” Clin Chem (1999) 45:295–6.
Buster JE, Casson PR, Straughn AB, Dale D, Umsot ES,
Chiamori N, Abraham GE, “Postmenopausal steroid
replacement with micronized dehydroepiandrosterone:
Preliminary oral bioavailability and dose
proportionality studies.” Am J Obstet Gynecol
(1992) 166: 1163-70
Casson PR, Buster JE. “DHEA replacement after
menopause: HRT 200 or nostrum of the ‘90s?”
Contemporary OB/GYN (1997) Apr:119–33.
Davidson MH, Weeks CE, Lardy H, et al. “Safety and
endocrine effects of 3-acetyl-7-oxo DHEA (7-keto
DHEA).” FASEB J (1998) 12:A4429.
Diamond P, Cusan L, Gomez JL, Belanger A, Labrie F.
“Metabolic effects of 12 month percutaneous
dehydroepiandrosterone replacement therapy in
postmenopausal women.” J Endocrinol (1996)
150:S43-S50
Ebeling P, Koivisto VA. “Physiological importance of
dehydroepiandrosterone.” Lancet (1994)
343:1479–81.
Flynn MA, Weaver-Osterholtz D, Sharpe-Timms KL, et
al. “Dehydroepiandrosterone replacement in aging
humans.” J Clin Endocrinol Metab (1999)
84:1527–33.
Gaby AR. “Dehydroepiandrosterone: biological effects
and clinical significance.” Altern Med Rev
(1996) 1:60–9 [review].
Glaser JL, Brind JL, Vogelman JH, Eisner MJ,
Dillbeck MC, Willace RK, Chopra D, Orentreich N.
“Elevated serum dehydroepiandrosterone sulfate
levels in practitioners of Transcendental Meditation
– TM.” J Behav Med (1992) 15(4):327-41
Heinz A, Weingartner H, George D, et al. “Severity
of depression in abstinent alcoholics is associated
with monoamine metabolites and
dehydroepiandrosterone-sulfate concentrations.”
Psychiatry Res (1999) 89:97–106.
Heuser I, Deuschle M, Luppa P, et al. “Increased
diurnal plasma concentrations of
dehydroepiandrosterone in depressed patients.” J
Clin Endocrinol Metab (1998) 83:3130–3.
Kalimi M, Regelson W. “The biological Role of
Dehydroepiandrosterone.” Walter de Gruyter,
Berlin (1990)
Lieberman, S., “An Abbreviated Account of Some
Aspects of the Biochemistry of DHEA”
Dehydroepiandrosterone (DHEA) and Aging, New
York Academy of Sciences Meeting, (1995) June 17-19
Majewska MD, “Neuronal actions of
dehydroepiandrosterone: Possible roles in brain
development, aging, memory and effect.” Ann NY
Acad Sci (1995) 774:111-9
Morales AJ, Nolan JJ, Nelson JC, Yen SSC. “Effects
of replacement dose of DHEA in men and women of
advancing age.” J Clin Endocrinol Metab
(1994) 78:1360.
Mortola J, Yen SSC. The effects of
dehydroepiandrosterone on endocrine-metabolic
parameters in postmenopausal women. J Clin
Endocrinol Metab (1990) 71:695–704.
Regelson W., “Hormone intervention: Buffer hormones
or state dependency. The role of
dehydroepiandosterone (DHEA), thyroid hormone,
estrogen and hypophysectomy in aging.” Annals New
York Acad of Sci (1988) 521:260-273.
Regelson W, Loria R, Kalimi M. “DHEA – the
Mother Steroid.” Ann NY Acad Sci (1994)
719:553-63
Reus VI, Wolkowitz OW, et. al. “H.
Dehydroepiandrosterone (DHEA) and memory in
depressed patients.” Neuropsychopharmacology
(1993) 9:66s
Robel P, Baulieu EE. “Dehydroepiandrosterone (DHEA)
is a neuroactive neurosteroid.” Ann NY Acad Sci
(1995) 774:82-110
Schneider LS, Hinsey M, Lyness S. Plasma
dehydroepiandrosterone sulfate in Alzheimer’s
disease. Biol Psychiatry (1992) 31:205–8.
Schwartz AG, Fairman DK and Pashko LL. “The
Biological Significance of Dehydroepiandrosterone”
In: The Biologic Role of Dehydroepiandrosterone (DHEA),
(1990) Walter de Gruyter, New York
Stomati M, Rubino S, Spinetti A, et al. “Endocrine,
neuroendocrine and behavioral effects of oral
dehydroepiandrosterone sulfate supplementation in
postmenopausal women.” Gynecol Endocrinol
(1999) 13:15–25.
Suitters AJ, Shaw S, Wales MR, Porter JP, Leonard J,
Woodger R, Brand H, Bodmer M, Foulkes R. “Immune
enhancing effects of dehydroepiandrosterone and
dehydroepiandrosterone sulfate and the role of
steroid sulfatase.” Immunology (1997 June)
91(2):314-21
Wolkowitz OM, Reus VI, Roberts E. “Antidepressant
and cognition-enhancing effects of DHEA in major
depression.” Ann NY Acad Sci (1995)
774:337-9
Wolkowitz OM, Reus VI, Roberts E.
“Dehydroepiandrosterone (DHEA) treatment of
depression.” Biological Psychiatry (1997)
41:331-318
Wolkowitz OM, Reus VI, Keebler A, et al.
“Double-blind treatment of major depression with
dehydroepiandrosterone.” Am J Psychiatry
(1999) 156:646–9.
Wolf OT, Neumann O, Hellhammer DH, et al. “Effects
of a two-week physiological dehydroepiandrosterone
substitution on cognitive performance and well-being
in healthy elderly women and men.” J Clin
Endocrinol Metab (1997) 82:2263–7.
Yen SS, Morales AJ, Khorram O. “Replacement of DHEA
in aging men and women.” Ann NY Acad Sci
(1995) 774:128-42
|
